prednisone has been researched along with Leukemia, Plasmacytic in 32 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 70-year-old man was diagnosed as plasma cell leukemia and one course of ranimustine-vindesine, melphalan, and prednisolone followed by melphalan and prednisone (MP) maintained a very good partial response." | 6.48 | Response to low-dose bortezomib in plasma cell leukemia patients with malignant pleural effusion and ascites: a case report and a review of the literature. ( Chigira, N; Ichikawa, K; Imai, H; Komatsu, N; Noguchi, M; Sawada, T; Sekiguchi, Y; Shirane, S; Sugimoto, K; Wakabayashi, M, 2012) |
| "Rapidly fatal acute myelomonocytic leukemia developed in five patients with multiple myeloma who were treated with melphalan for 28 to 54 months." | 3.65 | Multiple myeloma and acute leukemia associated with alkylating agents. ( Bayrd, ED; Kyle, RA; Pierre, RV, 1975) |
| "A 70-year-old man was diagnosed as plasma cell leukemia and one course of ranimustine-vindesine, melphalan, and prednisolone followed by melphalan and prednisone (MP) maintained a very good partial response." | 2.48 | Response to low-dose bortezomib in plasma cell leukemia patients with malignant pleural effusion and ascites: a case report and a review of the literature. ( Chigira, N; Ichikawa, K; Imai, H; Komatsu, N; Noguchi, M; Sawada, T; Sekiguchi, Y; Shirane, S; Sugimoto, K; Wakabayashi, M, 2012) |
| "Bortezomib was given at standard doses and schedules, in various combinations with dexamethasone, thalidomide, doxorubicin, melphalan, prednisone, vincristine, and cyclophosphamide." | 1.38 | Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. ( D'Arena, G; Di Renzo, N; Falcone, A; Ferrara, F; Guariglia, R; Mansueto, G; Martorelli, MC; Mastrullo, L; Musto, P; Onofrillo, D; Pagano, L; Palumbo, A; Pietrantuono, G; Semenzato, G; Specchia, G; Valentini, CG; Venditti, A; Villani, O, 2012) |
| "Like many other cases of primary plasma cell leukemia, this case suggests that CD56 may act as an adhesion molecule between neoplastic plasma cells and bone marrow stromal cells." | 1.31 | [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy]. ( Okuda, T; Shindo, T; Yoshida, M; Yumoto, Y, 2002) |
| "Nine patients were diagnosed with plasma cell leukemia (PCL) from 1982-1995 at our hospital." | 1.30 | [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases]. ( Calasanz Abinzano, MJ; Cuesta Palomero, B; Panizo Santos, C; Rifón Roca, J; Rocha Hernando, E, 1997) |
| "We report a case of de novo plasma cell leukemia, resistant to standard VMD (vincristine, mitoxantrone, dexamethasone) and CVP (cyclophosphamide, vincristine and prednisone) protocols, treated with a chemotherapy intensification regimen (high-dose cyclophosphamide, modified EDAP, Dexa-BEAM) and peripheral blood stem cell transplantation, performed using fractionated total body irradiation and high dose melphalan." | 1.29 | Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report. ( Bonini, A; Carotenuto, M; Cascavilla, N; D'Arena, G; Di Mauro, L; Greco, MM; Melillo, L; Minervini, MM; Musto, P; Sajeva, MR; Scalzulli, P, 1996) |
| "A case of non-secretory multiple myeloma presenting as primary plasma cell leukaemia in a 65 year old woman is presented." | 1.28 | Non-secretory multiple myeloma presenting as primary plasma cell leukaemia. ( Hernando, JC; Pais, JR; Pascual, J; Pérez Vaquero, MA; Sureda, A, 1992) |
| "Three of the four plasma cell leukemia cases presented a primary form, and one a secondary form." | 1.28 | [Plasma cell leukemia: our experience in 4 cases]. ( Bello, JL; Feliu, J; García de Bustos, J; Losada, G; Manso, F; Quevedo, E, 1991) |
| "Three patients with plasma cell leukemia are reported." | 1.27 | Plasma cell leukemia: a report on three patients. ( Cochi, S; De Laurenzi, A; Ferraro, P; Pacilli, L, 1983) |
| "Primary IgA plasma cell leukemia is a rare disorder in which hyperviscosity has not been reported." | 1.27 | Plasma cell leukemia with IgA paraproteinemia and hyperviscosity. ( Gale, RP; Kosmo, MA, 1988) |
| "Primary plasma cell leukemia was diagnosed in a previously healthy 58-year-old man." | 1.27 | Favorable response to aggressive chemotherapy in a patient with primary plasma cell leukemia. ( Jutrin, I; Lang, R; Lishner, M; Ravid, M, 1985) |
| "One of them showed blood picture of plasma cell leukemia." | 1.26 | Concomitant association of pyroglobulinemia and cryoglobulinemia in 2 patients in multiple myeloma. ( Hatake, K; Saito, K, 1982) |
| "A 76-year-old man with plasma cell leukemia was treated with L-phenylalanine mustard and prednisone (CLGB 7461)." | 1.26 | Plasma cell leukemia: response to conventional myeloma therapy. ( Gailani, S; Henderson, ES; Seon, BK, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (62.50) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 2 (6.25) | 29.6817 |
| 2010's | 5 (15.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, B | 1 |
| Sheaff, M | 1 |
| Blunden, M | 1 |
| Mangiacavalli, S | 1 |
| Pochintesta, L | 1 |
| Cocito, F | 1 |
| Pompa, A | 1 |
| Bernasconi, P | 1 |
| Cazzola, M | 1 |
| Corso, A | 1 |
| Chiu, W | 1 |
| Pullon, H | 1 |
| Woon, ST | 1 |
| Oei, P | 1 |
| The, R | 1 |
| Ameratunga, R | 1 |
| D'Arena, G | 2 |
| Valentini, CG | 1 |
| Pietrantuono, G | 1 |
| Guariglia, R | 1 |
| Martorelli, MC | 1 |
| Mansueto, G | 1 |
| Villani, O | 1 |
| Onofrillo, D | 1 |
| Falcone, A | 1 |
| Specchia, G | 1 |
| Semenzato, G | 1 |
| Di Renzo, N | 1 |
| Mastrullo, L | 1 |
| Venditti, A | 1 |
| Ferrara, F | 1 |
| Palumbo, A | 1 |
| Pagano, L | 1 |
| Musto, P | 2 |
| Sekiguchi, Y | 1 |
| Shirane, S | 1 |
| Imai, H | 1 |
| Sugimoto, K | 1 |
| Wakabayashi, M | 1 |
| Sawada, T | 1 |
| Chigira, N | 1 |
| Ichikawa, K | 1 |
| Komatsu, N | 1 |
| Noguchi, M | 1 |
| Pacilli, L | 1 |
| Ferraro, P | 1 |
| Cochi, S | 1 |
| De Laurenzi, A | 1 |
| Osanto, S | 1 |
| Müller, HP | 1 |
| Schuit, HR | 1 |
| Van Nieuwkoop, JA | 1 |
| Willemze, R | 1 |
| Anisimowicz, J | 1 |
| Mizan, K | 1 |
| Sala, P | 1 |
| Tonutti, E | 1 |
| Ruscio, M | 1 |
| Colle, R | 1 |
| Antonutto, G | 1 |
| Falconieri, G | 1 |
| Hatake, K | 1 |
| Saito, K | 1 |
| Sajeva, MR | 1 |
| Greco, MM | 1 |
| Cascavilla, N | 1 |
| Scalzulli, P | 1 |
| Melillo, L | 1 |
| Minervini, MM | 1 |
| Bonini, A | 1 |
| Di Mauro, L | 1 |
| Carotenuto, M | 1 |
| Panizo Santos, C | 1 |
| Cuesta Palomero, B | 1 |
| Calasanz Abinzano, MJ | 1 |
| Rifón Roca, J | 1 |
| Rocha Hernando, E | 1 |
| García-Sanz, R | 1 |
| Orfão, A | 1 |
| González, M | 1 |
| Tabernero, MD | 1 |
| Bladé, J | 1 |
| Moro, MJ | 1 |
| Fernández-Calvo, J | 1 |
| Sanz, MA | 1 |
| Pérez-Simón, JA | 1 |
| Rasillo, A | 1 |
| Miguel, JF | 1 |
| Piccinini, L | 1 |
| Artusi, T | 1 |
| Bonacorsi, G | 1 |
| Arigliano, V | 1 |
| Shindo, T | 1 |
| Yumoto, Y | 1 |
| Yoshida, M | 1 |
| Okuda, T | 1 |
| Gailani, S | 1 |
| Seon, BK | 1 |
| Henderson, ES | 1 |
| Spiegelberg, HL | 1 |
| Heath, VC | 1 |
| Lang, JE | 1 |
| Klein, B | 1 |
| Lewinski, U | 1 |
| Shabtai, F | 1 |
| Freidin, N | 1 |
| Djaldetti, M | 1 |
| Kyle, RA | 1 |
| Pierre, RV | 1 |
| Bayrd, ED | 1 |
| Fernández Rañada, JM | 1 |
| Ribera, C | 1 |
| López Pascual, J | 1 |
| Salazar, DG | 1 |
| Talero, D | 1 |
| Montero, J | 1 |
| Sureda, A | 2 |
| Pais, JR | 1 |
| Pascual, J | 1 |
| Pérez Vaquero, MA | 1 |
| Hernando, JC | 1 |
| Manso, F | 1 |
| Bello, JL | 1 |
| Feliu, J | 1 |
| García de Bustos, J | 1 |
| Losada, G | 1 |
| Quevedo, E | 1 |
| Pérez de Oteyza, J | 1 |
| García Laraña, J | 1 |
| Odriozola, J | 1 |
| Morey, M | 1 |
| Bargay, J | 1 |
| Galmes, A | 1 |
| Besalduch, J | 1 |
| Kosmo, MA | 1 |
| Gale, RP | 1 |
| Krsnik, I | 1 |
| Peñalver, MA | 1 |
| Del Potro, E | 1 |
| Diaz-Mediavilla, J | 1 |
| Lishner, M | 1 |
| Lang, R | 1 |
| Jutrin, I | 1 |
| Ravid, M | 1 |
| Montecucco, C | 1 |
| Riccardi, A | 1 |
| Merlini, G | 1 |
| Ascari, E | 1 |
| Shaw, MT | 1 |
| Twele, TW | 1 |
| Nordquist, RE | 1 |
| Stephens, PJ | 1 |
| Hudson, P | 1 |
| Andaloro, VA | 1 |
| Babott, D | 1 |
| Jean, G | 1 |
| Lambertenghi-Deliliers, G | 1 |
| Ranzi, T | 1 |
| Polli, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Mézières Method for The Use of Self in People With Low Back Pain. Mixed Study."[NCT03738306] | Early Phase 1 | 40 participants (Anticipated) | Interventional | 2019-02-28 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Leukemia, Plasmacytic
| Article | Year |
|---|---|
Response to low-dose bortezomib in plasma cell leukemia patients with malignant pleural effusion and ascites: a case report and a review of the literature.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Boronic Acids; | 2012 |
31 other studies available for prednisone and Leukemia, Plasmacytic
| Article | Year |
|---|---|
Plasma cell leukemia masquerading as a relapse of the Nephrotic syndrome.
Topics: Creatinine; Diagnosis, Differential; Female; Humans; Kidney; Leukemia, Plasma Cell; Middle Aged; Nep | 2018 |
Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Chromosomes, Human, | 2013 |
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
Topics: Aged; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Diphosphonates; Drug Therapy, Combinatio | 2010 |
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Borte | 2012 |
Plasma cell leukemia: a report on three patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Female; Humans | 1983 |
Primary plasma cell leukaemia. A case report and a review of the literature.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; | 1983 |
[Case of plasmacytic leukemia with complete remission and 1-year survival after a combined 5-drug sequence therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Ethamsylate; Female; Humans; | 1984 |
IgE myeloma. Report of a new case and review of the literature.
Topics: Aged; Drug Therapy, Combination; Female; Fructose; Humans; Immunoglobulin E; Indomethacin; Leukemia, | 1981 |
Concomitant association of pyroglobulinemia and cryoglobulinemia in 2 patients in multiple myeloma.
Topics: Bone Marrow; Cryoglobulins; Humans; Leukemia, Plasma Cell; Male; Mercaptopurine; Middle Aged; Multip | 1982 |
Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cyta | 1996 |
[Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; De | 1997 |
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Humans; Immuno | 1999 |
Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Clone Cells; Combined Modality | 2002 |
[Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Fem | 2002 |
Plasma cell leukemia: response to conventional myeloma therapy.
Topics: Aged; Humans; Leukemia, Plasma Cell; Male; Melphalan; Multiple Myeloma; Prednisone | 1977 |
IgG half-molecules: clinical and immunologic features in a patient with plasma cell leukemia.
Topics: Aged; Antibody Specificity; Bence Jones Protein; Bone Marrow Examination; Chromatography, DEAE-Cellu | 1975 |
Transmission and scanning electron microscopy study on plasma cell leukemia.
Topics: Acute Disease; Cell Nucleolus; Cell Nucleus; Endoplasmic Reticulum; Humans; Leukemia, Plasma Cell; M | 1977 |
Multiple myeloma and acute leukemia associated with alkylating agents.
Topics: Acute Disease; Aged; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Bone Neoplasms; Hemogl | 1975 |
[Plasma cell leukaemia. Haematological features and response to treatment (author's transl)].
Topics: Aged; Drug Therapy, Combination; Female; Humans; Immunoglobulin A; Immunoglobulin G; Leukemia, Plasm | 1975 |
Non-secretory multiple myeloma presenting as primary plasma cell leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; | 1992 |
[Plasma cell leukemia: our experience in 4 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1991 |
[Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Leukemia, Plas | 1989 |
[Plasma cell leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Humans; Leukemia, Plasma Ce | 1989 |
Plasma cell leukemia with IgA paraproteinemia and hyperviscosity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Cyclophosphamide; Cytarabine; Doxor | 1988 |
Complete remission in plasma cell leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Leukem | 1987 |
Favorable response to aggressive chemotherapy in a patient with primary plasma cell leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Pla | 1985 |
Complete remission in plasma cell leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Leukemia, Pla | 1986 |
Plasma cell leukemia: detailed studies and response to therapy.
Topics: Acid Phosphatase; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorescent Antibody Tech | 1974 |
Spontaneous rupture of the spleen on plasma cell leukemia.
Topics: Bence Jones Protein; Blood Protein Electrophoresis; Bone Marrow Examination; Diagnosis, Differential | 1969 |
Testicular involvement in plasma-cell leukemia.
Topics: Allopurinol; Cyclophosphamide; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple Myeloma; N | 1974 |
Ultrastructural aspects of bone marrow and peripheral blood cells in a case of plasma cell leukemia.
Topics: Agammaglobulinemia; Aged; Anti-Bacterial Agents; Bence Jones Protein; Blood Cells; Blood Transfusion | 1971 |